Answers are grounded in this paper and cite their sources.
Evaluates HER2 expression's role in risk stratification for ductal carcinoma in situ, suggesting new insights into tumor evolution.
HER2 expression redefined by the HER2-low concept reflects the biological diversity of DCIS. Evaluation of HER2 status as a continuous spectrum may aid in risk stratification and contribute to understanding early HER2-driven tumor evolution.
No takes yet. Share an insight, caveat, or question.
Takada et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: